Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

VentriPoint Diagnostics Ltd V.VPT

Alternate Symbol(s):  VPTDF

Healthcare Medical Devices
Ventripoint Diagnostics Ltd. is a Canada-based medical device company. It is engaged in the development and commercialization of diagnostic tools to monitor patients with heart disease. It develops a suite of applications for all heart diseases and imaging modalities, including congenital heart disease, pregnancy, pulmonary hypertension, COVID-19, technically difficult imaging and cardiotoxicity in oncology patients. It provides application of artificial intelligence to echocardiography. Its flagship product, Ventripoint Medical System (VMS+), enhances echocardiography to deliver cMRI levels of accuracy for volumetric measurements and ejection fractions for all four chambers of the heart. It has developed a solution that transforms cardiac care through its 3D ECHO and MRI software. VMS products are powered by its proprietary Knowledge Based Reconstruction technology, which is the result of a decade of development and provides accurate volumetric cardiac measurements equivalent to MRI.


TSXV:VPT - Post by User

VentriPoint Diagnostics Ltd > New Press Release - Ventripoint Receives Medical Device License from Health Canada to Sell Next Generation, AI-powered, Heart-scanning Technology
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(12)
•••
Comment by jopatcloon Aug 22, 2024 7:11am
60 Views
Post# 36191296

RE:RE:RE:RE:New Press Release - Ventripoint Receives Medical Device License from Health Canada to Sell Next Generation, AI-powered, Heart-scanning Technology

RE:RE:RE:RE:New Press Release - Ventripoint Receives Medical Device License from Health Canada to Sell Next Generation, AI-powered, Heart-scanning TechnologyFor you Pandora who loves every good news come post your FUD venom.Thanks to the negatives for diluting this news as usual today, I am a buyer Impressive The FUD team is working hard all at the same time! Like this week at the Mayo Clinic @cardinal their biggest of the big. What building is that Now that V4.0 is ok for Canada, exciting time .Solutions to cardiac clinicians worldwide. Ventripoint Diagnostics Ltd. has received a medical device license from Health Canada for its latest product offering, VMS+4.0. This is a major milestone for Ventripoint as it continues to innovate and provide cutting-edge solutions to cardiac clinicians worldwide. FDA V4.0 and Sales at any time now Insiders know!
<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities